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Summary 
Polyclonal stimulation of CD8 § cytotoxic T  lymphocytes (CTL) occurs during infection with 
many viruses including those not known to transform CTL or encode superantigens. This polyclonal 
CTL response includes the generation of high levels of allospecific CTL directed against many 
class I haplotypes. In this report we investigated whether the allospecific CTL generated during 
an acute lymphocytic choriomeningitis virus (LCMV) infection of C57BL/6 mice were stimulated 
specifically by antigen recognition or nonspecifically by polyclonal mechanisms possibly involving 
lymphokines or superantigens. An examination of the ability of different strains of mice to induce 
high levels of CTL specific for a given aUoantigen showed that most, but not all, strains generated 
high levels of allospecific CTL, and that their abilities to generate them mapped genetically to 
the major histocompatibility complex locus, exclusive of the class II region. This indicated that 
the virus-induced allospecific CTL generation was independent of the class II aUotype, and mice 
depleted of CD4 + cells generated allospecific CTL, indicating independence of class II-CD4 + 
cell interactions and resulting CD4 + cell-secreted lymphokines. FACS  |  staining with a variety 
of V:/-binding antibodies did not show a superantigen-like depletion or enrichment of any tested 
V/~ +  subset  during  infection.  Several  experiments  provided  evidence  in  support  of  direct 
stimulation of CD8 + cells via the T  cell receptor: (a) both virus- and allo-specific killing were 
enriched within a given V3 subpopulation; (b) relative CTL precursor frequencies against different 
class I alloantigens changed during the course of virus infection; (c) the relative levels of virus- 
induced, allospecific CTL-mediated lysis at day 8 after infection did not parallel the CTL precursor 
frequencies before infection; and (d) limiting dilution analyses  of day 8 LCMV-infected spleen 
cells stimulated by virus-infected syngeneic peritoneal exudate cells (PEC) revealed not only the 
expected virus-specific CTL clones, but also a high frequency of clones that were cross-reactive 
with allogeneic and virus-infected syngeneic targets. In addition to the virus cross-reactive allospecific 
CTL clones, virus-infected PEC also stimulated the generation of some allospecific clones that 
did not lyse virus-infected fibroblasts. Surprisingly, LCMV-infected PEC were much more efficient 
at stimulating allospecific CTL clones from day 8 LCMV-infected splenocytes than were allogeneic 
stimulators. These results indicate that at least part of the polyclonal allospecific CTL response 
elicited by acute virus infection is a consequence of the selective expansion of many clones of 
allospecific CTL which cross-react with virus-infected cells. These CTL may contribute to the 
early control of virus infection, when the viral burden is great, and before significant numbers 
of high affinity virus-specific CTL are generated. 
M 
assive proliferative lymphocyte responses to virus in- 
fections have been shown with transforming viruses 
such as EBV in B cells (1) and with superantigen-encoding 
viruses, such as mouse mammary tumor virus (MMTV) 1 in 
1 Abbreviations used in this paper." c-RPMI,  complete RPMI;  FBS,  fetal 
bovine serum;  i, intercept, LCMV, lymphocytic choriomeningitis virus; 
LDA,  limiting dilution assay; LU,  lyric unit;  MCMV,  murine  cyto- 
megalovirus; MMTV, mouse mammary tumor virus; MOI, multiplicity 
of infection;  PEC, peritoneal exudate cell; pf, precursor frequency. 
CD4 + T cells (2), but a profound polyclonal stimulation of 
CD8 §  T  cells appears to be also a natural consequence of 
infections with viruses not known to transform cells or to 
encode superantigen (3).  In addition to the stimulation of 
virus-specific CTL, acute virus infections stimulate the gener- 
ation of high levels of allospecific CTL and the reactivation 
of memory CTL specific for viruses from prior infections (4). 
This induced allospecific CTL response has been shown during 
infections with lymphocytic choriomeningitis virus (LCMV), 
vaccinia virus (VV), Pichinde virus (PV), and murine cyto- 
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humans  (5, 6), Acute virus infections such as mouse hepa- 
titis virus (strain JHM) (7) and Coxsackie B3 virus (CVB3) 
(8, 9) in the mouse and Kilham rat virus in the rat (10) have 
been reported to stimulate autoimmune T cells. The allospecitic 
CTL induced in mice by LCMV or in humans by EBV infec- 
tion have been shown to recognize the class I antigens on 
a broad range of allogeneic targets,  indicating  that  a large 
spectrum of TCR specificities  are elicited (6).  This would 
suggest  that  virus infection  causes many of the CD8 + T 
cells to proliferate and differentiate,  and indeed, during the 
first 8 d of an acute LCMV infection, the number of CD8 + 
cells  in  the  spleen increases  15-20-fold,  whereas  the  total 
number of spleen cells increases  two-four-fold over that of 
the uninfected spleen. Many of these virus-induced  CD8 § 
T  cells express activation markers.  Approximately 75% ex- 
press CD44, "~50% express CD11b (11), and "~25% express 
the large granular lymphocyte phenotype of cytotoxic cells (12). 
The consequences of this polyclonal T  cell response are 
as yet undetermined,  but these CTL have  the potential  to 
contribute to autoimmunity and graft rejection. In addition, 
if the allospecific CTL represent selective expansions of virus- 
spedfic CTL which are cross-reactive with alloantigens, they 
may provide an early, important,  and rapidly mobilized im- 
mune response to control virus infection and spread in the host. 
The question we address in this report is whether the pro- 
found levels of CD8 + cell proliferation and the induction of 
allospecific CTL are stimulated by an antigen-driven mecha- 
nism  involving  occupation  of the TCK by viral or virus- 
induced  antigens,  or whether  they are  a consequence of a 
TCR-independent mechanism induced by the complex array 
of lymphokines produced during  an acute virus infection. 
We have previously reported  that  the killing  of allogeneic 
targets was not impaired by coincubation with unlabeled virus- 
infected syngeneic targets (4). This argued that the allospedfic 
CTL response was not cross-reactive with the virus-specific 
response,  and  this result,  along with  the observation that 
targets expressing all tested allogeneic class I aUotypes (H- 
2d'f'k'P  'r's) were lysed by CTL from C57BL/6 mice (H-2b), 
led us to speculate that this may be a cytokine-driven poly- 
clonal response independent of TCR stimulation.  However, 
we also discussed that affinity differences of the CTL for the 
targets in cold target competition assays could account for 
lack of competition for T cells that recognize both targets (4). 
The approach we have taken here to address these issues 
is to look for preferential  selection of particular allospecifidties 
over others during virus infection,  and to determine if the 
virus-induced allospecific  CTL are cross-reactive with viral 
antigen at the clonal level.  In addition,  we map genetically 
the generation  of virus-induced  allospecific  CTL to MHC 
regions external to the class II genes and demonstrate that 
CD4 + cells do not play a prominent  role in this induction 
process. We report that there is an active selection of aUospecific 
CTL subsets during acute virus infection and that  this can 
be attributed, at least in part, to cross-reactivity of virus-specific 
CTL clones for alloantigen. 
Materials and Methods 
Mice.  Most strains of mice were purchased from The Jackson 
Laboratory  (Bar Harbor,  ME).  These included the H-2  b strains 
C57BL/6J,  C57BL/10J,  and  C3H.SW/SnJ;  H-2  a  strains 
BALB/cbyJ, DBA/2J and B10.D2/nSnJ; H-2  k strains C3H/HeSnJ 
and  B10.BR/SgSnJ;  and  strains of other  haplotypes  such  as 
B10.M/Sn (H-2f), C3H.NB/Sn (H-2P), SWR/J (H-2q), B10.RJII- 
(71NS)/SnJ (H-2r), and A.SW/SnJ (H-2'). The H-2' strain B10.S 
was purchased from Harlan  Sprague Dawley, Inc. (Indianapolis, 
IN).  The  recombinant  strains A.TBR1  (H-2  'tl)  and  A.TBR2 
(H-2  '~2) (13) were  kindly  provided  by Dr.  Howard  Pessmore 
(ILutgers University, New Brunswick, NJ). Mice were used at 1-6 
mo of age. 
Viruses.  The Armstrong strain of LCMV was used in all ex- 
periments. The virus was propagated on baby hamster kidney calls 
as reported dsewhere (14). Mice were injected intraperitoneally with 
4  x  104 PFU of LCMV for 7 or 8 d unless otherwise indicated. 
LCMV-immune mice were given secondary LCMV infection by 
injection with 4  x  104 PFU of LCMV at least 4 wk after the pri- 
mary LCMV infection. 
Target Cells,  L929 (H-2k), a continuous  liver cell line derived 
from  C3H  mice, and  MC57G  (H-2S), a methylcholanthrene- 
induced flbroblast cell line from C57BL/6 mice were propagated 
in MEM (Gibco Laboratories, Grand Island, NY) supplemented 
with 100 U/ml penicillin G, 100/,g/ml streptomycin sulfate, 2 mM 
t-glutamine,  and 10% heat inactivated (56~  30 rain) fetal bovine 
serum (FBS) (Sigma Chemical Co., St. Louis, MO). P815 (H-2a), 
a methylcholanthrene-induced mastocytoma from DBA/2 mice, was 
maintained in 1LPMI media (Sigma Chemical Co.) supplemented 
as described for complete MEM (c-RPMI).  KO cells (H-2b), a 
SV40-transformed cell line derived from a C57BL/6 mouse (15) 
and provided to us by Dr, Satvir Tevethia (Pennsylvania State Med- 
ical Center, Hershey, PA) were propagated in DMEM (Gibco Labora- 
tories) supplemented as described for MEM, but with the addition 
of 5  x  10 -s M 2qvt~ and 10 mM Hepes. MC57G, KO, and L929 
cells were infected with LCMV at a multiplicity of infection (MOI) 
of 0.1-0.2  PFU/cell  and incubated for 2 d at 37~ 
Depletion of NK Cells In  Viw  Mice were injected intraperi- 
toneally with 5/,1 of antiserum to asialo GM1 (Wako Chemical, 
Dallas, TX) in a volume of 0.1 ml on days 0 and 4 after infection. 
This greatly reduced NK cell activity for at least an 8-d time period. 
Effector (Respander) Cell Preparation.  Spleens  were isolated and 
ground between the frosted ends of two glass microscope slides. 
The cell suspension was then passed through a fine nylon mesh 
to obtain a single cell suspension. Erythrocytes were lysed by briefly 
resuspending the spleen cell pellet in 0.84% NH4C1 solution be- 
fore rinsing. For CD8 + effector cells, 10  s spleen cells were stained 
with 50/,1 of directly FITC-conjugated,  purified anti-CD8  anti- 
body (Becton Dickinson & Co., Mountain View, CA) for 45 rain 
on ice and rinsed three times before sorting, The stained cells were 
compared with unstained cells for background fluorescence  and sepa- 
rated  into  CD8-  and  CD8 + subpopulations  at  a flow rate  of 
2,000-2,500  cellsA using a cell sorter (FACS  |  440; Becton Dick- 
inson & Co.). For TCR V~/staining of effector cells, tissue culture 
supernatants from hybridomas (V/36 [ILK 4-7]; V/$ 8.1 and 8.0 
[KJ 16.133.18]; V~ 11 (RR3-15]; Vl3 9 [MR 10-2]; VB 5.1 and 
5.2 [MR 9.4]; and V/3 17 [KJ 23.588.1]), kindly provided by Dr. 
Ed Palmer (National Jewish Center for Immunology and Respira- 
tory Medicine, Denver, CO) were used. The cells were incubated 
for 45 min on ice, rinsed three times, and treated with a mouse 
FITC-conjugated F(ab')z anti-rat  IgG F(ab')z (Jackson Immunore- 
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anti-mouse Ig (Zymed, San Francisco,  CA) for 30 rain on ice and 
rinsed three times. Streptavidin (Becton Dickinson & Co., San Jose, 
CA) was added to the biotin-treated samples for 30 rain on ice 
and washed three times. The stained cells were sorted as described 
above. 
Cytotoxicity Assay.  Cell-mediated cytotoxicity was determined 
using a standard microcytotoxicity (CTL) assay (16). MC57G, KO, 
L929, or P815 target cells (1-5  x  106) were pelleted,  resuspended 
in 0.1 ml of Na-SlCr (Amersham Corp., Arlington Heights, IL), 
and incubated for 45 min at 37~  in a humidified 5% COs incu- 
bator. The targets were rinsed three times in RPMI, resuspended 
to  10Vml  in  c-RPMI,  and  0.05  or 0.1  ml  was  added  to  flat- 
bottomed microtiter wells in quadruplicate (Costar Corp., Cam- 
bridge, MA). For the CD8 inhibition studies,  0.05 ml of anti-Lyt 
2 antibody (dilution of M12:17.2  ascites,  kindly provided by Dr. 
Eric Martz (University of Massachusetts, MA) (17) was added to 
the  plates  for  the  duration  of the  SlCr-release  assay.  Varying 
numbers of effector leukocytes were added in 0.1  ml of medium 
to achieve the desired E/T ratios. For a spontaneous SlCr-release 
control, 0.1 ml of c-RPMI was added to the labeled target cells 
in place of effector cells. For the maximum S~Cr-release control, 
0.1 ml of 1% NP-40 was added to target cells. After 6-8 h at 37~ 
the microtiter plates were centrifuged at 200g for 5 min. Superna- 
rant was removed (0.1 ml) from each well and counted on a gamma 
counter (model 5000; Beckman Instruments, Inc., Palo Alto, CA). 
Data were expressed as percent specific SlCr-release =  100  x  [(ex- 
perimental cpm -  spontaneous release cpm)/maximum release cpm 
-  spontaneous release  cpm)]. Lyric units were calculated using 
the exponential fit and yon Kroegh methods (18) provided by soft- 
ware (Proteins International, Rochester Hills, MI). One lytic unit 
was defined as the number of effector cells required to lyse a given 
percentage of a population  of 104 targets in an 8-h CTL assay. 
In Vivo Depletion of eD4 § Cells.  CD4 + cells were depleted fol- 
lowing the procedure of Bullet et al.  (19). Briefly, 0.1 ml of GK 
1.5 hybridoma ascites propagated in BALB/c mice in our facility, 
control ascites from BALB/c, or PBS was injected intraperitoneally 
on  -4,  -2, and  +3 d after infection to deplete CD4 + cells. On 
the day of the assay, the mice were bled to determine IgG levels 
in the serum. The spleens were removed and used in cell-mediated 
cytotoxicity assays and FACS  |  analyses to determine the presence 
or absence of CD4 + cells using a mouse FITC-conjugated F(ab')2 
anti-rat  IgG F(ab')2 second  antibody (Jackson Immunoresearch 
Laboratories). IgG levels were determined by cytoplasmic staining 
of fixed LCMV-infected MC57G cells using serial dilutions of con- 
trol  and  CD4 + cell-depleted  sera.  The  second  antibody was  a 
FITC-labeled goat anti-mouse IgG (Zymed). 
Limiting Dilution Assay (LDA) for Virus-Specific CTL Precursors. 
The assays used the procedure of Moskophides et al. (20) with the 
following modifications. Stimulators were prepared from perito- 
neal exudate cells (PEC), isolated from C57BL/6 mice having re- 
ceived 1 ml of thioglycollate broth (Difco Laboratories Inc., Detroit, 
MI) intraperitoneally before plating. The PEC were infected with 
an MOI of 0.1 PFU of LCMV and plated in 96-well,  U-bottomed 
microtiter dishes (Costar Corp.) at 5  x  104 per/well in 0.1 ml cul- 
ture media. After 2 d in culture, the 96-well plates received 2,000 
rad of 137Cesium gamma irradiation from an irradiator (Gammacell 
40;  Atomic Energy of Canada,  Ltd.,  Ottawa, Canada).  Culture 
medium was removed (50 #1) from each well and replaced with 
50 #1 of media containing  10  S irradiated  (2,000  rad),  syngeneic 
spleen  cells.  Varying numbers of responder cells from C57BL/6 
spleens  were added in 0.1  ml of media to 16-32 well replicates, 
and the plates were cultured at 37~  in a humidified COs (5%) 
incubator.  After 4 d,  the cultures were fed by removing 0.1  ml 
of media from each well and adding  5  x  104 irradiated,  virus- 
infected PEC in 0.1 ml of media. The culture medium throughout 
the assay was either c-RPMI (Sigma Chemical Co.) supplemented 
with 0.1 mM nonessential amino acids (Gibco Laboratories), 0.1 
#M sodium pyruvate (Gibco Laboratories), 1% 1 M  Hepes, and 
5  x  10-s M  2-ME (MLC-RPMI) or complete AIM V medium 
(Gibco Laboratories) supplemented with 10% heat-inactivated  FCS. 
Growth factors were provided by the addition of 25% culture su- 
pematant from the IL-2-secreting, gibbon lymphoma tumor cell 
line MLA.144 (American Type Culture Collection, Rockville, MD) 
(21). On days 5-8 of culture, individual wells were split three- or 
fourfold and assayed for cytolytic function on infected or uninfected 
syngeneic target cells (MC57G or KO) and on allogeneic target 
cells  (L929  and P815)  using a modified SlCr-release  assay. 51Cr- 
labeled targets (5  x  103) were added to all wells  to allow a final 
volume of 200/zl/well.  The plates were incubated 8 h  at 37~ 
centrifuged for 5 min at 130 g  (IEC CRU-5000 centrifuge), and 
0.1  ml of supernatant was harvested.  Radioactivity released  into 
the supernatant was counted on a gamma counter (Beckman In- 
struments, Inc.). Positive wells were defined as those wells whose 
SlCr-release exceeded the mean spontaneous release by >3 SD. All 
wells  that lysed uninfected  syngeneic targets or lysed all targets 
tested were eliminated from the analysis. Frequencies  were calcu- 
lated using X  2 analysis  according to Taswell (22)  on a computer 
program kindly provided by Dr.  Richard  Miller  (University of 
Michigan,  Ann Arbor, MI). 
LDA to Determine Precursor  Frequencies of  Allospecific CTL.  A1- 
logeneic stimulator cells were prepared from the spleens of allogeneic 
mice irradiated  (2,000 rad)  1 h  before killing.  Varying numbers 
of responder spleen cells (from infected or control mice) were cul- 
tivated in 96-well  flat-bottomed microtiter plates (Costar Corp.) 
in the presence of 106 irradiated allogeneic spleen  cells in 0.2 ml 
supernatant-supplemented MLC-RPMI (as described above). The 
cultures  were incubated  at  37~  in  a  humidified  5%  COs  at- 
mosphere for 4 d,  at which  time they were fed by replacing 0.1 
ml of the culture medium in each well with fresh supplemented 
MLC-RPMI.  After 4 d more of culture,  a modified SlCr-release 
assay and precursor analyses  were performed as described above. 
MLC.  For micro MLC, 2  x  10  s irradiated, allogeneic stimu- 
lator cells were plated into flat-bottomed microtiter wells (Costar 
Corp.) Doses ranging from 25 to 200  x  104 responder cells in 0.1 
ml volume of MLC-RPMI were added to the stimulators in replicas 
of four wells. The cultures were incubated in a 37~  humidified, 
5%  CO2 incubator for 4 d.  SlCr-labeled  target cells (10 4,  P815, 
L929, and MC57G) in 50 #1 of c-RPMI were added to each cul- 
ture well. For spontaneous release of SlCr, targets were added to 
wells  containing  only medium.  For  maximum release  of S:Cr, 
targets were added to wells  that contained 0.1  ml of 1% NP-40 
in PBS. The plates were incubated for 6 h at 37~  in a humidified 
incubator, centrifuged at 130g, and 0.1 ml of supernatant was re- 
moved from each well and counted in a gamma counter (Beckman 
Instruments, Inc.). The percent specific 51Cr-release was calculated 
as described above. Standard MLC were prepared by incubating 2 
x  107 effectors  in the presence of 8  x  107 irradiated,  allogeneic 
stimulator cells in 25 ml of MLC-RPMI in a 25 cm  2 flask (Costar 
Corp.).  These were incubated in the upright position,  37~  in 
a humidified 5% CO2 incubator for 4 d. The viable cells were col- 
lected and used as effectors  in the standard cytotoxicity assay de- 
scribed above. 
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Induction of  Allospecific CTL and Their Sensitivity to Treatment 
with Anti-CD8 mAb.  Table 1 (Expts. 1, 2, and 3) shows that 
at 8 d after primary infection, high levels of cytotoxicity de- 
velop against LCMV-infected syngeneic targets, and moderate 
levels of cytotoxidty develop against the uninfected allogeneic 
H-2  k and H-2  a targets.  Virtually no cytotoxicity was ob- 
served against uninfected syngeneic  targets in these mice, which 
had been depleted of NK cells. We have previously shown 
that this cytotoxic activity is mediated by CD8 § CTL (3). 
The CD8 molecule on the surface of CTL is responsible for 
strengthening low affinity interactions between the CTL and 
the target cell by binding to the o~3 domain of the class I 
MHC molecule (23). Antibodies directed against CD8 are 
thought to inhibit the interactions of low affinity CTL more 
than those of high affinity (24). We questioned whether there 
were differences in the CD8 requirements between the virus- 
and allospecific CTL-mediated lysis. Table 1 shows the effects 
of anti-CD8  antibody on the lysis of LCMV-infected syn- 
geneic targets (H-2  b  +  LCMV) and allogeneic targets (H-2  k 
and H-2 d) by day 8  LCMV-infected  spleen cells in a SlCr- 
release  assay.  With  excess  anti-CD8  antibody,  there  was 
significant inhibition in the lysis of both allogeneic and virus- 
infected syngeneic targets, though a small component of the 
virus-specific killing was not inhibited. This contrasts with 
the high affinity, uninhibitable interactions  seen with allo- 
or  virus-specific CTL,  respectively, from secondary MLC 
(Expts. 2 and 3) or from secondary in vivo virus infection 
(Expt.  4). 
The Induction of Virus-Induced  Allospecific CTL in Congenic 
and Recombinant Strains of  Mice.  The levels of LCMV-induced 
allospecific CTL generation varied with the strain of mice 
(Fig.  1).  H-2  k ~ar strains  generated relatively low levels of 
lysis against the targets L929 (H-2  k) and P815 (H-2a); H-2  b, 
f, p, ,~d s strains generated high levels.  We questioned what 
genetic factors contributed to this strain variation and tested 
the ability of various congenic mouse strains to generate anti- 
H-2  d CTL after LCMV infection. The allospecific CTL in- 
duction  against  H-2  a  targets  mapped  within  the  MHC. 
Congenic strains that presented the H-2  b (C57BL/6, C57BL/ 
Table  1.  Inhibition of Virus- and Allospecific Lysis by Anti-CD8 Antibody 
Expt.  Effectors 
Targets 
H-2  b  +  LCMV  H-2  a  H-2  k  H-2  b 
E/T  44-50  22-25  12  50  10-12  3  50  10-12  3  50  10-12  3 
1.  LCMV-infected H-2  b  76 
LCMV  +  anti-CD8  30 
2.  LCMV-infected H-2  b  67 
LCMV  +  anti-CD8  36 
2 ~ MLC (H-2  b anti-H-2  a) 
2 ~ MLC (H-2  b anti-H-2  a) 
+  anti-CD8 
2 ~ MLC (H-2  b anti-H-2  k) 
2 ~ MLC (H-2  b anti-H-2  k) 
+  anti-CD8 
3.  LCMV-infected H-2  b 
LCMV-infected H-2  b 
+  anti-CD8 
2 ~ MLC (H-2  b anti-H-2  a) 
2 ~ MLC (H-2  b anti-H-2  a) 
+  anti-CD8 
4.  2 ~ LCMV-infected H-2  b 
2 ~ LCMV-infected H-2  b 
+  anti-CD8 
57  22  6  22  10 
16  5  3  8  2 
38  27  10  27  10 
9  6  4  6  2 
31  14 
30  9 
30  11 
22  8 
36  19  17  4  17  5  3 
20  10  1  1  8  2  3 
67  28 
56  25 
29  17 
21  14 
2  3 
-2  -4 
9  7 
4  3 
1  6 
1  1 
2 
-4 
7  1 
5  2 
C57BL/6 mice were infected with LCMV for 8 d before the assay. The 2  ~ MLC effectors  were C57BL/6 spleen cells primed in vivo with allogeneic 
tumor cells (P815 or L929) for 1-2 mo before 2  ~ stimulation in vitro. The 2  ~ LCMV-induced effectors were C57BL/6 spleen cells that were infected 
with LCMV in vivo 1-2 mo before secondary LCMV infection for 6 d in vivo. The anti-Lyt 2 (anti-CDS) antibody was titrated for maximum 
inhibition of virus-specific lysis and was used in the SlCr-release assay at 1:300-600 dilution. Target cells: H-2  b, MC57G; H-2  d, P815; and H-2  k, L929. 
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Figure  1.  Levels  ofLCMV-induced allospecific CTL in different strains 
of mice.  100:1 E/T ratio.  Data represent  average lysis from six experi- 
ments using C57BL/6; four experiments using A.SW; three experiments 
using C3H.NB and C3H; two experiments  using B10.RIII; and one ex- 
periment using B10.M and B10.S. 
10,  C3H.SW)  haplotype generated higher levels  of virus- 
induced H-2d-specific CTL  than  those  that  presented the 
H-2 k haplotype (B10.BR,  C3H)  (Fig. 2).  The C3H  strain 
contains high NK cell activity, and it is sometimes difficult 
to completely eliminate its NK  cell activity by anti-asialo 
GM, injections, as higher concentrations of anti-asialo GM1 
inhibit CTL generation. To facilitate the distinction between 
nonspecific NK-like vs. allospecific cytotoxicity, the killing 
against syngeneic targets, presumably mostly NK cell medi- 
ated, is also presented in this figure. To more precisely map 
within the MHC locus the gene region which was associated 
with virus-induced alloreactivity, recombinant mice that ex- 
pressed high responder haplotype (H-2' ~d b) at the class  I 
alleles and low responder haplotype (H-2 k) at the class II al- 
H-2  k BI0.BRk 
n-2  C3H 
H-2 b  C3H.SW 
[ 
~  SYNGENglC  I 
H  2  ~  P615 
H-2 b  B10.J 
H-2 b  C57BL/6 
p  I  r  I  p 
0  fl  I(]  15  20  ,25  ~0 
% LYSIS 
Figure  2.  The generation of virus-induced  allospecific CTL in MHC 
congenic mice. NK cell-depleted mice were infected with I.CMV 7 d be- 
fore CTL assay. Splenocytes were tested for cytotoxicity against  the al- 
logeneic target, P815 (H-2d), and against infected and uninfected syngeneic 
target cells, The syngeneic target for H-2  b effectors was MC57G and for 
H-2  k effectors, L929.  100:1 E/T ratio.  The average of the virus-specific 
lysis between strains  at an E/T ratio of 100:1 was 65  _+  10%. 
leles were tested. As shown in Hg. 3, mice with low responder 
alleles at the I-A (A.TBR2), or I-A and I-E (A.TBK1) gener- 
ated high levels of aUospecific CTL. This result shows that 
the generation of allospecific CTL maps outside the class II 
region. In these and in a variety of other experiments, high 
responder class I alleles (b or s) overlapping either the K or 
D class I loci resulted in a high allospecific CTL phenotype. 
No congenic mice were available that expressed high responder 
alleles  Co or s) at the class II loci and low responder alleles 
(k) at all the class  I loci, but the data are consistent with 
the concept that  relative levels  of LCMV inducton of al- 
lospecific CTL may involve the class I loci and are indepen- 
dent of the class  II haplotype. 
Generation of Virus-induced Allospecific  CTL In Vivo in the 
Absence  of CD4 + Cells.  To  determine  if the  aUospecific 
CTL generated during acute virus infection were being stimu- 
lated by high levels of I1.-2 or other growth factors secreted 
by activated CD4 + T cells, C57BL/6 mice were depleted of 
CD4 + cells  by multiple intraperitoneal  injections of anti- 
CD4 antibody (GK 1.5) or control ascites before and during 
the acute infection with LCMV. The effector cells were also 
depleted in vivo of NK cell activity with antibody to asialo 
GMt to eliminate background NK cell-mediated lysis. Fig. 
4 shows that spleen cells from C57BL/6 (H-2 b) mice treated 
with control ascites lysed allogeneic P815 and L929 cells and 
virus-infected but not uninfected, syngeneic MC57G cells. 
The depletion of CD4 § T  cells did not affect the induction 
of allospecific CTL, nor, as shown previously by others, did 
it  reduce virus-specific killing  (25)  (Fig.  4).  Cytoplasmic 
staining of LCMV-infected MC57G cells with sera collected 
H-2  k  [~  H-2  d  [~  H-2  b  ~  SYN.  +  LCMV 
H-2  b  C57BL/6 
H-2  f  B10.M 
H-2  k  CSH 
H-2  p  C3H.NB 
A.TBRI  A.TBR2  C3H 
(s  k  k  b)  (s  k  b  b)  (k  k  k  k) 
Figure  3.  Induction ofallospecific CTL during LCMV infection of class 
I and II recombinant strains of mice. The analyses ofLCMV-infected A.TBR1 
and A.TBR2 strains were based on the average lysis by splenocytes from 
four individual spleens. Representative data from two C3H mice were in- 
cluded. Other C3H data are presented in Figs. 1 and 2. The LCMV-infected 
syngeneic target for A.TBR1 and A.TBR2 strains was MC57G, and for 
C3H strain,  L929. 
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Figure 4.  The generation of virus-induced allospecific  CTL in CD4 + 
cell-depleted mice. Data were averaged from three experiments using a 
cumulative total of seven spleens from LCMV-infected  C57BL/6 (H-2  b) 
mice. 100:1 E/T ratio. 
from the antibody-  or sham-treated  mice showed that  the 
production  of  antiviral  IgG,  a  CD4 §  T  cell-dependent 
event, was reduced by '~ 1,000-fold in the anti-CD4 antibody- 
treated mice, and FACS  |  showed that the lymphocyte popu- 
lation was largely depleted of CD4 § cells (data not shown). 
These results indicate that the polyclonal stimulation of al- 
lospecific CTL during virus infection does not require high 
levels  of  the  lymphokines  secreted  by  the  CD4 +  T  cell 
population. 
Lack of Evidence for a CD8 + T  Celt Superantigen Response. 
"Superantigen"-encoding  pathogens  such  as  MMTV  and 
Staphylococcus preferentially stimulate the expansion of pe- 
ripheral  CD4 §  T  cells  expressing  particular  V3  in  their 
TCR  (2,  26).  To  determine  whether  LCMV-induced  al- 
lospecific CTL were the result of the expansion of CD8 + 
T  cells activated by an LCMV-induced or -encoded superan- 
tigen, spleen cells from LCMV-infected and control C57BL/6 
mice were stained with a panel of TCR V3 antibodies (V3 
5,  6,  8,  9,  11,  and  17).  In confirmation of work  reported 
previously for some of the V3  genes  (27),  no  skewing  of 
the VB usage was apparent in the CTL population after 7 d 
of LCMV infection, arguing against the possibility that the 
allospecific CTL are responding  to  superantigen  (data  not 
shown). 
Selective  Expansion  of 1-t-2  k vs.  1-1-2  d Allospecificity  in  the 
LCMV-infected C57BL/6 Mouse.  A possible mechanism for 
the induction of allospecific CTL during  acute virus infec- 
tion is that they are cross-reactive CTL selected to proliferate 
via TCR occupancy by a viral or endogenous antigen presented 
in the context of self MHC class I antigen. If so, the response 
should not be absolutely "polyclonal" but more oligoclonal, 
and the relative numbers of allospecific CTL (H-2  a vs. H-2  k) 
and their precursors before and after infection should change 
depending upon which alloantigen more closely resembles 
the conformation of self MHC  and antigen that is driving 
the stimulation in vivo. LDA, MLC,  and CTL assays were 
performed to determine the responsiveness of uninfected and 
day 8  LCMV-infected C57BL/6  (H-2  b)  spleen cells  to the 
H-2  k  or  H-2  a  alloantigen.  MLC  of uninfected  C57BL/6 
(H-2  b) spleen cells cultured in the presence of irradiated H-2  d 
(BALB/c or DBA/2) or H-2  k (C3H or B10.BR) spleen cells 
show  that  the  lyric  units  (LU)  spedfic  for  H-2  k  targets 
(L929)  were  only  half as  great  as  those  for  H-2  d targets 
(P815) (ratio, 0.47  +  0.07) (Table 2). This ratio is reflected 
in  the  precursor  frequency estimation  of H-2  k-  or  H-2  d- 
specifc  CTL  in  the  uninfected  C57BL/6  spleen  (1/6553 
[H-2  k]  vs.  1/3412  [H-2a],  respectively,  in  paired  experi- 
ments). Yet, in spleen cells taken 8 d after LCMV infection, 
there  were  approximately  equivalent  CTL  precursor  fre- 
quencies (H-2  k, 1/3,407 vs.  H-2  a,  1/3,739),  as well as com- 
parable amounts of killing in SlCr-release assays against the 
two  alloantigens  (H-2  k,  1.68  LU  vs.  H-2  a  =  1.29  LU) 
(Table  2).  More  often  than  not,  the  direct  virus-induced 
allospecific CTL-mediated lysis was greater against the H-2  k 
(L929)  cell  target  than  the  H-2  d (P815)  cell  target,  even 
though  these  mice  had  twice  as  many  H-2a-specific  pre- 
cursors before infection. These results demonstrate a greater 
selection of H-2  k- than H-2d-specific CTL and suggest that 
Table  2.  Preferential Stimulation  of 1-t-2  k CTL  during 
LCMV Infection 
Relative response 
Assay  Effectors  H-2VH-2  a 
MLC  H-2  b spleen  cells  0.48* 
LDA  H-2  b spleen  cells  0.52* 
CTL  H-2  b LCMV-infected 
spleen  cells  1.49s 
LDA  H-2  b LCMV-infected 
spleen  cells  0.9111 
* The relative response is based on LU of H-2k- and H-2d-specific  lysis 
by C57BL/6 spleen cells in the micro MLC. Data presented are the aver- 
age LU of two representative experiments: 0.48  +  0.08 SD. 
* The relative response is based on precursor frequencies (pf) of H-2k- 
and H-2a-specific  CTL in the uninfected C57BL/6 spleen. Data represent 
the average  precursor frequencies  in three experiments in which both the 
H-2  k- and H-2d-specific  precursors were estimated from the same spleen 
cell population. For the  H-2  k precursor analyses: the  average pf  = 
6,553  _+ 435, p  =  0.67 +_ 0.07, and the intercept (i) -  0.99  _+ 0.05. 
For the H-2  a precursor analyses: average pf =  3,412 _+  1,669, p  = 
0.68  _+ 0.47, and i  m 0.97  +_ 0.02. 
S  The relative response is based on lysis (LU) of H-2  k (L929) and H-2  d 
(P815) targets by LCMV-infected C57BL/6 spleen cells in an 8-h slCr- 
release assay. Data  represent the  average LU  in  two  experiments: 
1.49 _+ 0.28. 
II The relative response is based on pf of H-2  k- and H-2a-specific  CTL 
in the LCMV-infected C57BL/6 spleen. Data represent the average of 
H-2a-specific pf in five experiments and H-2k-specific  pf in four experi- 
ments. Average H-2a-specific  pf ~  3,739 _+ 1,339, p  -  0.68  +  0.17, 
and i  m 1.02 +_ 0.08. Average H-2  k- specific  pf =  3,407 _+ 1,157, p 
=  0.64  _+ 0.15, andi  =  1.09 _+ 0.15. 
322  Virus-induced  Cross-reactive Cytotoxic T Lymphocytes Table  3.  Virus-specific  and Allospecific Lysis by V~8 + LCMV-infected Spleen Cells 
Lysis by effector cells 
Stained 
Expt.  Targets  unsorted  V3 8 +  V3  8- 
1  H-2  b  +  LCMV  9.3"  47.7  10.8 
H-2  k  2.2  6.3  2.8 
2  H-2  b  +  LCMV  16.1  141.0  12.0 
H-2  k  8.0  79.3  4.9 
C57BL/6 mice were infected with LCMV for 8 d, stained and sorted for VB 8 expression, and tested for lysis against L929 (H-2  k) and LCMV- 
infected MC57G (H-2  b +  LCMV) targets in a standard SlCr-release assay. Effector cells in expt. 1 were enriched for T cells by panning (31). Whole 
spleen leukocytes were used in expt.  2. 
" Lysis is represented in LU/IO  6 cells. 
the virus-induced alloreactivity may be due to the selective 
expansion  of discrete clones of allospecific CTL. 
Representation of Both  Virus- and H-2~-specific CTL  in the 
Vff8 + Population of Virus-infected Spleen Cells.  To determine 
the relationship between the virus- and allospecific CTL, we 
questioned whether a population of T  cells bearing a given 
VB and enriched for virus-specific CTL activity would also 
be enriched for allospecific CTL activity. The V3  8  TCR 
was selected because it is expressed on a greater number of 
T  cells in the C57BL/6 mouse (27) than other V3 TCR for 
which there are antibodies. When LCMV-infected spleen cells 
were sorted using flow cytometry for expression of V3 8 + 
TCR,  virus-  and allospecific lysis were both highly repre- 
sented in the V3 8 + population (Table 3),  suggesting  that 
phenotypically similar cells are mediating both functions. This 
experiment also formerly proves that at least some of the al- 
lospecific CTL response is mediated by conventional CTL 
expressing TCR-3.  Substantial virus- and allospecific CTL 
activity was  also found in the V3  8-  populations. 
Cross-reactivity  of Short-Term LCMVspecific CTL Clones Gener- 
ated in LDA.  An explanation for the preferential selection 
of certain allospecific CTL specificities could be that the abun- 
dance of viral antigen present during  acute virus infection 
stimulates  the proliferation of any CTL with  the capacity 
to bind or cross-react with the viral peptide-self-MHC class 
I complex. Some of these CTL might be cross-reactive with 
alloantigen. To determine if the selection of allospecific CTL 
was due to cross-reactivity with virus-infected cells,  short- 
term (4-8 d in culture) virus-specific CTL clones were gener- 
ated in LDA and tested in split-well analyses for cross-reactivity 
against LCMV-infected and uninfected syngeneic (H-2  b) and 
uninfected H-2 k or H-2  d aUogeneic targets. Fig. 5 shows the 
LDA of CD8 +  splenic T  cells taken from mice at  days 5, 
7, 8, and 9 after infection. The precursor frequency of virus- 
specific CD8 §  T  cells derived from C57BL/6  mice peaked 
at 7 d of LCMV infection, but was estimated to be only 1 
in 61 CD8 + spleen cells (Fig. 5), despite the fact that most 
of  the  CD8 §  cells  at  that  time  point  have  an  activated 
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phenotype (11).  This demonstrates  how only a very small 
subpopulation  of this  activated  CD8 +  T  cell  population 
grows out in these LDA. The precursor frequency was deter- 
mined for each experiment, and all the culture wells estimated 
to  contain  ~<0.5 virus-specific CTL/well  were  exposed  to 
5tCr-labeled  allogeneic  targets  to  determine  if any  of the 
100 
￿9  Day  5  i/pf=618 
￿9  Day  7  i/pf=61 
￿9  Day  8  I/pf=li8 




250  500  750  1000  1250  1500 
EFFECTOR  CELLS/WELL 
Figure 5.  LDA  of LCMV-specific CTL precursors per  CD8 §  cell 
during  LCMV infection of the C57BL/6  mouse. Four representative 
precursor  analyses  from different  days after  infection  are shown. The effectors 
for days 7 and 8 after infection were CD8 + sorted cells. The precursor 
analyses for days 5 and 9 after infection used unsorted spleen cells, and 
the CD8 + CTL precursor frequency was estimated based on the per- 
centage of CD8 + calls in the starting population. Intersection with the 
horizontal line represents the point at which 37% of the wells were nega- 
tive and the precursor frequency  was estimated. Thep value and intercept 
for each regression plot were as follows: day 5, p  -  0.99, i =  1.07; day 
7, p  -  0.93,  i  -  0.84;  day 8, p  =  0.99,  i  m  1.00; and day 9, p  =  0.95, 
i -  1.1. The I.CMV-infected  target was KO and lysis of uninfected KO 
cells was below 3 SD of their spontaneous slCr-release. virus-specific clones also lysed allogeneic targets.  As can be 
seen in Table 4, experiments 1-5 generated high levels of virus- 
specific  CTL  cross-reactive with  H-2  k or H-2  d (27/78  or 
35%) and used a commercially available, supplemented RPMI 
medium. Experiments 6-11 used an alternative  medium, AIM 
V, which generated similar virus-specific CTL precursor fre- 
quencies but with  greater rates of cell proliferation  in  the 
8-d culture period. Lower, but still significant levels of CTL 
cross-reactive with H-2  k were stimulated with this proprie- 
tary medium (11/114 or 10%) (Table 4). This lower level of 
cross-reactivity in the AIM V media suggests that the cross- 
reactive allospecific CTL may have different growth require- 
ments  than  some of the virus-specific CTL. 
The generation of the high levels of allospecific CTL clones 
required virus-infected PEC for their stimulation, suggesting 
that the clones must cross-react with virus-infected PEC. It 
could be argued, however, that a strong virus-specific T cell 
reaction  might  provide factors for a bystander stimulation 
of allospecific CTL without recognition of the virus-infected 
PEC by the allospecific CTL. Analyses indicated that the cross- 
reactive CTL were, indeed, clones and not mixtures of two 
CTL clones, each with  a different specificity.  There was a 
linear single-hit distribution of aUospecific killing at limiting 
concentrations, indicating that the allospecific CTL were not 
dependent  on a second (i.e.,  virus  specific)  T  cell type for 
their  generation.  The  precursor  frequencies for the virus- 
specific CTL were not of a sufficient magnitude to contaminate 
all the wells of allospecific  CTL precursors and to allow for 
linear allospecific kinetics in an environment of excess virus- 
specific "helper cells." Statistical  analysis (X  2, goodness of fit) 
of the distribution of clones at <0.5 spleen cells/well showed 
that the cross-reactive clones were not merely due to the chance 
appearance  of an alloreactive clone in the same well as a virus- 
Table  4.  Specificities of Short-Term, LCMV-induced CTL 
Clones (I-I-29 
No. of clones 
Expt.  1-2  3-5  6-11 
Clone  specificities  (KPMI)  (KPMI)  (AIM V) 
1. LCMV  +  H-2  b  36  42  114 
2.  H-2  k  24  19  25 
3.  H-2  a  5  ND  ND 
4.  LCMV  +  H-2  b and H-2  k  15  9  11 
5. LCMV  +  H-2  b and H-2  a  3  ND  ND 
6.  H-2  k alone  7  10  14 
7.  H-2  d alone  2  ND  ND 
8.  H-2  k and d  2  ND  ND 
Lines 1-3 represent the specificities  of the total numbers of clones gener- 
ated in expts. 1-11. Lines 4-8 represent the fine specificities  of the clones 
listed in rows 1-3. The media used for each experiment is represented 
in parentheses. 
specific clone, because many more wells showed lysis of both 
allogeneic and virus-infected targets than would have if the 
cross-reactivity were attributable to a random association of 
two  dones  (two-tail  X  2  p  value  <0.001;  Fisher  value 
<0.001%). In summary, these analyses of short-term, virus- 
specific CTL clones show that a significant amount of the allo- 
reactivity seen during LCMV infection can be attributed to 
virus-specific CTL that cross-react with allogeneic H-2  k or d 
MHC antigens (38/192 or 20%) (Table 4) and that the out- 
growth of these CTL is sensitive to indeterminate  factors 
present  in media. 
The Generation of  Allospecific CTL Clones not Lrtic for Virus- 
infected Syngeneic Fibroblasts.  The virus-specific, allo-cross- 
reactive CTL clones generated in LDA did not account for 
all of the allospecific  CTL clones. Split-well analyses also re- 
vealed allospecific  dones that were stimulated to proliferate 
in vitro with virus-infected, syngeneic PECs, but were un- 
able to lyse the infected,  syngeneic fibroblast cell line, MC57G. 
Under the limiting conditions that generated 192 H-2  b plus 
virus-specific CTL clones (where the effector cell density was 
<0.5 virus-specific CTL/well), 35 clones were found to lyse 
only the allogeneic target,  L929 (H-2  k) or P815  (H-2  d) or 
both, but not the virus-infected or uninfected syngeneic targets, 
MC57G or KO cells (Table 3). The generation of allospecific 
CTL occurred in the LDA cultures stimulated with virus- 
infected PEC but not with uninfected PEC (data not shown). 
The allospecific  clones appeared in wells seeded with fewer 
than 250 spleen cells, which was a remarkably high frequency 
approaching  that of virus-specific CTL.  These results sug- 
gest that these allospecific CTL recognized (a) a viral antigen 
presented by LCMV-infected PEC, but not by virus-infected 
MC57G  or  KO  cells;  (b)  virus-induced  cellular  antigens 
presented on the PEC;  or (c) presented viral antigens with 
affinities sufficient for stimulation of proliferation  and differen- 
tiation, but not sufficient for cytotoxicity against virus-infected 
targets. 
Allospecific CTL Precursors Generated in Response to Alloeeneic 
Stimulators vs. Virus-infected Syngeneic Stimulators.  When day 
8 LCMV-infected spleen cells  were stimulated with virus- 
infected PEC,  the detected precursors for H-2  a- and H-2  k- 
specific CTL were much more frequent than when PEC ex- 
pressing the respective alloantigen were used to stimulate the 
spleen  cell  population.  The  frequency  of  H-2k-specific 
precursors was 1 in 213 (p,  0.24;  intercept,  1.01) in day 8 
spleen cells using virus-infected PEC to stimulate,  whereas 
H-2k-presenting  stimulators  (irradiated  spleen  cells  from 
B10.BR or C3H mice) yielded an average precursor frequency 
of 1 in 3,407 from day 8 spleen cells (Table 2). Similarly,  the 
precursor frequencies for H-2a-specific CTL in  acutely in- 
fected spleens  was 1 in 346 (p,  0.31; intercept,  1.07)  using 
virus antigen  to stimulate vs.  1 in 3,739 using alloantigen 
to stimulate (Table 2). These surprising results in LDA indi- 
cate that in a virus-induced T  cell population, viral antigen 
is  better  than  alloantigen  at  inducing  allospecific  CTL 
precursors. 
Stability of Cwss-reactive Clones.  If more than  one CTL 
clone was responding in the cross-reactive wells, one might 
expect that over time the specificity would drift toward one 
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Figure  6.  Specificities of long-term  LCMV-induced  clones.  Clones 
generated in LDA were cultured for 4 wk and challenged against LCMV- 
infected  MC57G (H-2~),  L929 (1-1-2  ;~) and P815 (/-/-2  d) cells. Any clone 
which killed all three targets  was considered nonspecific and eliminated 
from the analysis. 
reactivity or be lost.  This did not occur in six clones that 
were maintained for 4 wk in culture. The first clone main- 
tained specificity for L929  (H-2k),  the second was  cross- 
reactive for L929  (H-2  k) and virus antigen, the third was 
specific for P815 (H-2  d) and L929 (H-2k),  and the remaining 
three  were  specific  for  virus-modified  self (i.e.,  H-2  b  + 
LCMV) but not H-2  a or H-2  k (Fig.  6). 
Discussion 
These results show that infection with a nontransforming 
virus elicits a profound polyclonal CTL response in the ab- 
sence of any detectable V~-binding superantigens, as significant 
alterations in the numbers of cells expressing TCR V~ genes 
are not observed during infection. Although not all VB gene 
products were examined, the expansion of an untested V~ 
subset should still lead to a reduction in other subsets, which 
did not occur. A corollary of this polyclonal CTL response 
was the generation of low affnity, allospecific  CTL,  inde- 
pendent of CD4 + T cells or the allotype of the class II an- 
tigens. The target of the allospecific CTL was shown previ- 
ously to be class I MHC antigens (4), and the ability of various 
strains of mice to generate high levels of CTL to a given allo- 
type mapped to the MHC locus outside of the class II re- 
gion, and may in fact be a product of the T  cell repertoire 
educated by host class I antigens. At least a portion of the 
allospecific  CTL response generated during acute virus in- 
fection is due to a selective stimulation of many, though dis- 
crete, clones bearing cross-reactivity with syngeneic cells ex- 
pressing viral antigen. Many of the allospecific CTL generated 
in vivo and detected directly in cytotoxicity assays probably 
have a low affnity for virus-modified self because unlabeled 
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virus-infected targets did not interfere with the lysis of ra- 
diolabeled allogeneic targets in bulk cytotoxicity assays (3). 
Additionally, however, the allospecific  CTL are themselves 
probably of  low affinity, as their ability to lyse allogeneic targets 
is highly inhibitable by anti-CD8 antibody (Table  1).  The 
large range of allogeneic haplotypes recognized (4) implies 
that the numbers of these allospecific  CTL must be great. 
This  may provide  an  explanation  for  why  virus-specific 
precursor frequencies are only 1 in 61  CD8 + cells  in the 
spleen (Fig.  5), yet 1 in 4 of the CD8 + ceUs in the day 7 
LCMV-infected spleen have the large granular lymphocyte 
morphology characteristic of activated cytotoxic cells (12). 
The majority of the CTL present in the acutely infected spleen 
may not proliferate in our LDA because their affnity for virus 
is too low, yet the allospecific CTL probably proliferate in 
vivo, as we have shown previously that both the allospecific 
and virus-specific cells are found in the blast-sized cell frac- 
tions (4). 
"Affnity" as it is used here, is a loosely defined term which 
in the case of the CTL probably includes not only the phys- 
ical affnity of the TCR for MHC plus peptide (which has 
been shown to be a very weak interaction) (28), but also the 
interactions of accessory molecules and their receptors (CD2- 
LFA 3; CD8-MHC; CDllb-intercellular adhesion molecule 
(ICAM)-I or C3bi;  and LFA-I-ICAM-1 or 2), as has been 
suggested by Williams et al. (29). In contrast with the acute 
infection, the precursor frequencies of virus-specific CTL in 
the peritoneal cavity of mice 2 mo after infection correlate 
closely with  the numbers  of CD8 +  CTL  expressing the 
memory CDllb + phenotype in vivo (data not shown) and 
are quite high (>1 in 10), indicating that there is no inherent 
poor efficiency  in generating precursors in the LDA and sug- 
gest that the LDA culture conditions may be favoring the 
proliferation of memory cells. The high frequency of cross- 
reactive clones generated in short-term LDA from acutely 
infected splenocytes contrasts with reports on the specificities 
of a number of LCMV-specific clones generated in long-term, 
bulk cultures. These highly selected clones show no cross- 
reactivity with H-2  a or k alloantigens (30). 
It is surprising that we found many CTL clones whose 
proliferation depended upon virus-infected PEC, but which 
were able to lyse only allogeneic cells but not virus-infected 
fibroblast targets. These CTL may have been cross-reactive 
for self PEC antigens induced by virus infection or for viral 
antigens presented by the virus-infected PEC used to stimu- 
late their growth, but not presented on the virus-infected 
fibroblasts used for assaying their cytotoxicity. This distinc- 
tion will be addressed in future experiments. Recently there 
have been reports of virus infections inducing autoimmune 
T cells in the mouse (7-9) and the rat (10). Some of the al- 
lospecific  CTL observed in our studies may be stimulated 
by a virus-induced, tissue-specific  neo-antigen to which the 
host is not tolerized. 
PV, MCMV, W, and LCMV induce allospecific CTL, sug- 
gesting that the aUospecific CTL induction is a normal part 
of the immune response to virus infection (4). We propose 
that these cross-reactive CTL may play an important role in 
viral clearance at early times after infection when the viral burden is great, before high affinity CTL appear  in large 
numbers. These cells may be directly cytotoxic to virus-infected 
targets in vivo or secrete cytokines amplifying other clear- 
ance mechanisms and possibly the proliferation of CD8 + 
cells. The fact that so many CD8 + cells respond to infec- 
tion may provide an explanation as to why many virus-specific 
CTL responses do not require help from CD4 + T cells (25). 
It has been suggested (Hagerty, D. T., and E M. Allen, manu- 
script submitted for publication) that high concentrations 
of antigen select a broad range of TCR affinities whereas low 
concentrations of antigen select high affinity T cells. LCMV 
grows to very high titers in the spleens of the mouse during 
the first few days of infection, and this would allow efficient 
antigen presentation to CTL with a broad range of affinities 
for virus plus MHC class I. Presumably, high affinity CTL 
would be selected as the virus is cleared, and antigen becomes 
rare. 
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